Ann Kapoun, Ph.D.
Senior Vice President, Research & Development
Ann Kapoun, Ph.D., serves as SVP, Research & Development. She brings to E-Scape more than two decades of leadership and experience overseeing the transition of > 10 drug discoveries through early clinical development.
Prior to E-Scape, Dr. Kapoun served as SVP of Translational Medicine at OncoMed Pharmaceauticals where she oversaw broad functions in preclinical and translational drug development through Phase 2 and was responsible for the clinical execution and implementation of biomarkers and companion diagnostics. In previous roles, Dr. Kapoun established and built highly effective translational departments from inception at ALZA / Johnson & Johnson, where she was as Associate Director of Biomarker R&D in Clinical Pharmacology & Experimental Medicine, and at Scios Inc. where she created and led their Biomarker and Pharmacogenomics programs in support of multiple phase 1-3 clinical trials. Dr. Kapoun received her Ph.D. at Howard Hughes Medical Institute, Indiana University, and she has coauthored more than 50 scientific publications and patents.